Literature DB >> 21398582

Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.

Takuya Yamamoto1, David A Price, Joseph P Casazza, Guido Ferrari, Martha Nason, Pratip K Chattopadhyay, Mario Roederer, Emma Gostick, Peter D Katsikis, Daniel C Douek, Richard Haubrich, Constantinos Petrovas, Richard A Koup.   

Abstract

A highly complex network of coinhibitory and costimulatory receptors regulates the outcome of virus-specific CD8(+) T-cell responses. Here, we report on the expression patterns of multiple inhibitory receptors on HIV-specific, cytomegalovirus-specific, and bulk CD8(+) T-cell memory populations. In contrast to cytomegalovirus-specific CD8(+) T cells, the majority of HIV-specific CD8(+) T cells exhibited an immature phenotype and expressed Programmed Death-1, CD160 and 2B4 but not lymphocyte activation gene-3. Notably, before antiretroviral therapy, simultaneous expression of these negative regulators correlated strongly with both HIV load and impaired cytokine production. Suppression of HIV replication by antiretroviral therapy was associated with reduced surface expression of inhibitory molecules on HIV-specific CD8(+) T cells. Furthermore, in vitro manipulation of Programmed Death-1 and 2B4 inhibitory pathways increased the proliferative capacity of HIV-specific CD8(+) T cells. Thus, multiple coinhibitory receptors can affect the development of HIV-specific CD8(+) T-cell responses and, by extension, represent potential targets for new immune-based interventions in HIV-infected persons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398582      PMCID: PMC3100691          DOI: 10.1182/blood-2010-11-317297

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

Review 1.  Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.

Authors:  Swapnil V Vaidya; Porunelloor A Mathew
Journal:  Immunol Lett       Date:  2006-03-15       Impact factor: 3.685

2.  Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L.

Authors:  Jacob Bukczynski; Tao Wen; Chao Wang; Natasha Christie; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Colin M Kovacs; Kelly S Macdonald; Mario Ostrowski; Rafick-Pierre Sekaly; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

3.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.

Authors:  D Moskophidis; F Lechner; H Pircher; R M Zinkernagel
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

Review 5.  Phenotype and function of human T lymphocyte subsets: consensus and issues.

Authors:  Victor Appay; Rene A W van Lier; Federica Sallusto; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Authors:  David A Price; Jason M Brenchley; Laura E Ruff; Michael R Betts; Brenna J Hill; Mario Roederer; Richard A Koup; Steven A Migueles; Emma Gostick; Linda Wooldridge; Andrew K Sewell; Mark Connors; Daniel C Douek
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

10.  Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

Authors:  Nobuhiro Nakamoto; Hyosun Cho; Abraham Shaked; Kim Olthoff; Mary E Valiga; Mary Kaminski; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

View more
  112 in total

1.  Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.

Authors:  Joseph A Conrad; Ramesh K Ramalingam; Coley B Duncan; Rita M Smith; Jie Wei; Louise Barnett; Brenna C Simons; Shelly L Lorey; Spyros A Kalams
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  Immunotherapy for lung cancer.

Authors:  María González-Cao
Journal:  Transl Lung Cancer Res       Date:  2015-12

3.  Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.

Authors:  Anna Lissina; David R Ambrozak; Kristin L Boswell; Wenjing Yang; Eli Boritz; Yoshiyuki Wakabayashi; Maria C Iglesias; Masao Hashimoto; Masafumi Takiguchi; Elias Haddad; Daniel C Douek; Jun Zhu; Richard A Koup; Takuya Yamamoto; Victor Appay
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

Review 4.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

Review 5.  Association of HLA-alleles with the immune regulation of chronic viral infections.

Authors:  Shokrollah Elahi; Helen Horton
Journal:  Int J Biochem Cell Biol       Date:  2012-05-14       Impact factor: 5.085

6.  Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.

Authors:  Filippos Porichis; Douglas S Kwon; Jennifer Zupkosky; Daniel P Tighe; Ashley McMullen; Mark A Brockman; David F Pavlik; Marta Rodriguez-Garcia; Florencia Pereyra; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

7.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

8.  Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression.

Authors:  Rachel Lena Rutishauser; Wendy Hartogensis; Christian Deo Deguit; Melissa Krone; Rebecca Hoh; Frederick M Hecht; Christopher D Pilcher; Peter Bacchetti; Steven G Deeks; Peter W Hunt; Joseph M McCune
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-25       Impact factor: 2.205

Review 9.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

10.  Standardization and quality control for high-dimensional mass cytometry studies of human samples.

Authors:  Katja Kleinsteuber; Björn Corleis; Narges Rashidi; Nzuekoh Nchinda; Antonella Lisanti; Josalyn L Cho; Benjamin D Medoff; Douglas Kwon; Bruce D Walker
Journal:  Cytometry A       Date:  2016-08-30       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.